Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance.
Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, Pinner RW, Hajjeh RA. Kao AS, et al. Among authors: baughman ws. Clin Infect Dis. 1999 Nov;29(5):1164-70. doi: 10.1086/313450. Clin Infect Dis. 1999. PMID: 10524958
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.
Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T. Lockhart SR, et al. J Clin Microbiol. 2012 Nov;50(11):3435-42. doi: 10.1128/JCM.01283-12. Epub 2012 Aug 8. J Clin Microbiol. 2012. PMID: 22875889 Free PMC article.
The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000.
Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, Gardner T, Sattah M, de Leon GP, Baughman W, Hajjeh RA. Mirza SA, et al. Clin Infect Dis. 2003 Mar 15;36(6):789-94. doi: 10.1086/368091. Epub 2003 Feb 27. Clin Infect Dis. 2003. PMID: 12627365
Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae.
Van Beneden CA, Lexau C, Baughman W, Barnes B, Bennett N, Cassidy PM, Pass M, Gelling L, Barrett NL, Zell ER, Whitney CG. Van Beneden CA, et al. Emerg Infect Dis. 2003 Sep;9(9):1089-95. doi: 10.3201/eid0909.020620. Emerg Infect Dis. 2003. PMID: 14519245 Free PMC article.
Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease.
Kellerman SE, McCombs K, Ray M, Baughman W, Reeves MW, Popovic T, Rosenstein NE, Farley MM, Blake P, Stephens DS; Georgia Emerging Infections Program. Kellerman SE, et al. J Infect Dis. 2002 Jul 1;186(1):40-8. doi: 10.1086/341067. Epub 2002 Jun 7. J Infect Dis. 2002. PMID: 12089660
Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment.
Stephens DS, Zughaier SM, Whitney CG, Baughman WS, Barker L, Gay K, Jackson D, Orenstein WA, Arnold K, Schuchat A, Farley MM; Georgia Emerging Infections Program. Stephens DS, et al. Among authors: baughman ws. Lancet. 2005 Mar 5-11;365(9462):855-63. doi: 10.1016/S0140-6736(05)71043-6. Lancet. 2005. PMID: 15752529
Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.
Albrich WC, Baughman W, Schmotzer B, Farley MM. Albrich WC, et al. Clin Infect Dis. 2007 Jun 15;44(12):1569-76. doi: 10.1086/518149. Epub 2007 May 8. Clin Infect Dis. 2007. PMID: 17516400
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.
Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network. Robinson KA, et al. JAMA. 2001 Apr 4;285(13):1729-35. doi: 10.1001/jama.285.13.1729. JAMA. 2001. PMID: 11277827
The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment.
Gay K, Baughman W, Miller Y, Jackson D, Whitney CG, Schuchat A, Farley MM, Tenover F, Stephens DS. Gay K, et al. J Infect Dis. 2000 Nov;182(5):1417-24. doi: 10.1086/315853. Epub 2000 Oct 9. J Infect Dis. 2000. PMID: 11023465
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group.
Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW. Hajjeh RA, et al. J Infect Dis. 1999 Feb;179(2):449-54. doi: 10.1086/314606. J Infect Dis. 1999. PMID: 9878030
14 results
Jump to page
Feedback